跳至主要内容
临床试验/NCT03428074
NCT03428074已完成不适用

A Multi-centre Real-world Non-interventional Observational Study to Compare Effectiveness and Safety of the Minimally Invasive Surgeries of Ivor-Lewis and Mckeown in Chinese Patients With IA-IIIB Esophageal Cancer

Chinese PLA General Hospital9 个研究点 分布在 1 个国家目标入组 1,862 人开始时间: 2017年12月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
1,862
试验地点
9
主要终点
Overall survivals in patients with esophageal cancer who received surgeries

研究概览

简要总结

The study was designed to compare effectiveness and safety of the surgeries of Ivor-Lewis and Mckeown in patients with esophageal cancer

详细描述

The trial is a multi-centre real-world non-interventional observational study. The study was designed to compare effectiveness and safety of the minimally invasive surgeries of Ivor-Lewis and Mckeown in the Chinese patients with IA-IIIB esophageal cancer via a retrospectively review method based on the study data on patient demographic/tumor biological characteristics and clinical treatments.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Pathologically diagnosed middle and lower thoracic IA-IIIB esophageal cancer after surgeries;
  • Patients who received minimally invasive radical dissections of Ivor-Lewis and Mckeown;
  • Patients who received tubular gastroesophageal reconstruction;

排除标准

  • Patients complicated with arrhythmia, or serious disfunctions of heart, lung, liver, and kidney before surgeries;
  • Patients with second primary tumors;
  • Patients who received abdominal or thoracic surgeries;
  • Patients who received gastrostomy or nesteostomy before surgeries;
  • Patients with suspected cervical lymph metastases (in the subgroup of the patients who received the surgery of Mckeown)

结局指标

主要结局

Overall survivals in patients with esophageal cancer who received surgeries

时间窗: 2010 - 2017

Overall survivals in patients with esophageal cancer who received surgeries categorised by tumor biological characteristics

次要结局

  • Death rates within 30 days after surgeries(2010 - 2017)

研究者

发起方
Chinese PLA General Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Yang Liu

Professor

Chinese PLA General Hospital

研究点 (9)

Loading locations...

相似试验